REGISTRATION

REGISTER TODAY TO GET THE ONLINE DISCOUNTED RATE: $125

AT THE DOOR: $150

EPPICon 2018 SPEAKERS

Welcome Address

9AM - 9:15AM

Ashutosh Shastry, President, EPPIC Global

Opening Keynote

9:15AM - 9:45AM

Neil Kumar, CEO and Founder, BridgeBio

  • null

    Fireside chat: AI and big data in Clinical Development

    9.45AM - 10.45AM
    • Vipin Gopal, Chief Data and Analytics Officer, Eli Lilly
    • Sanjay Joshi, CTO, H20.ai
    • Jafar Shenasa, VP, Regulatory Affairs, Proteus Digital Health
    • Jason Paragas, Director of Innovation, Lawrence Livermore National Laboratory
    • Abhijit Thatte, VP, Artificial Intelligence, Aricent

Break

10:45AM - 11AM

  • null

    Real world data driven drug development and treatments

    11AM - 12:15PM
    • Jacqueline Law, Global Head, Real World Data Science, Genentech
    • Ken Carson, Senior Medical Director, Flatiron Health
    • Iya Khalil, Co-Founder, GNS Healthcare
    • Noga Leviner, Co-Founder and CEO, Picnic Health
    • Gracie Lieberman, Director of Regulatory Policy, Genentech

Lunch (Networking open)

12:15PM - 1:15PM

  • null

    Conference Co-Chair Remarks

    1:15PM - 1:30PM

  • null

    Keynote: Genomics and Personalized Medicine

    1:30PM - 2PM

    Christine (Chris) Bakan, VP, Head of software and bioinformatics at Roche Sequencing Solutions

  • null

    Digital health and clinical decision support

    2PM - 3:15PM
    • Darshan Gandhi, Heme/Oncologist, Head of Venture Innovations, Methodist Health System
    • Mamatha Shekar, Director, Biomedical Informatics, Illumina
    • Aashima Gupta, Global Head - Healthcare Solutions, Google Cloud Platform at Google
    • Raj Harapanahalli, Head of Roche Diagnostic Information Solutions (DIS)

Break

3:15AM - 3:30AM

  • null

    Speed Pitch

    3:30PM - 4:30PM
    • Ted Driscoll, Managing Partner, DigitalDx Ventures
    • Radhika Iyengar, Founding Partner, StarChain Ventures
    • Faz K. Bashi, Investor

  • null

    Closing Keynote

    4:30PM - 5PM
    • Serafim Batzoglou, VP, Applied and computational Biology, Illumina

Reception 5PM Onwards

"

VC and audience feedback at EPPICon Speed Pitch helped me update the pitch for our company. I was able to connect with lawyers and a CMC consultant, which was very helpful in rounding out the company and helping us close a $12M round later in the year

"

Pradeep Fernandes, Co-founder and CEO, Stealth mode start-up

Pitch your idea to our VC panel at EPPICon 2018!

SUBMIT

Who Should Attend

Stakeholders empowering the entire health eco system through technology

Stakeholders

  • Innovators
  • Researchers
  • Enterpreneurs
  • Investors
  • Payers
  • Providers
  • Employers
  • Regulators
  • Policymakers
  • Retailers
  • Consultants

Health Eco System

  • Pharma
  • Biotech
  • Diagnostics
  • Devices
  • Clinical decision support

Technology

  • Digital health solutions through use of big data
  • Analytics
  • AI
  • Machine learning

EPPICon 2018 SPONSORS

EPPICon 2018 CO-CHAIRS

Details

RAVI SRINIVASAN, PhD

Cofounder & CEO, OncoNano Medicine

Dr. Ravi Srinivasan is a seasoned healthcare executive, serial entrepreneur and scientist. He is the Cofounder and CEO of OncoNano Medicine, a clinical stage company developing therapeutic and imaging products targeting pH disorders in diseases such as cancer. He has previously founded StemPar Sciences, an oncology company, and StrataGent Life Sciences, a dermatology company. Ravi is an inventor in over 50 patents and has developed award winning products such as the Microjet “patch-pump” for delivering injectables like insulin painlessly through the skin (Edison award 2010). He has also served in senior executive, product development and manufacturing roles in silicon valley healthcare companies including SEA Medical, Corium, and ForSight V5. Dr. Srinivasan received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.Tech. from IIT Mumbai.

Details

ASHUTOSH SHASTRY, PhD

President, EPPIC
CTO, Evanostics

Dr. Ashutosh Shastry is the Chief Technology Officer at Evanostics – a medical diagnostics company focused on developing products that re-imagine drug testing and helping resolve the raging opioid crisis in the US. Dr. Shastry has over 15 years of experience developing biosensors and multidisciplinary teams, medical devices and platforms for drug delivery and diagnostics. Utilizing his deep experience with microsystems engineering, Dr. Shastry currently leads the product and technology development for the Evanostics point-of-care detection system. Prior to joining Evanostics, Dr. Shastry served as Vice President R&D at iNDx LifeCare, and as the Director of Engineering at Corium International, Inc. At Corium, he led the technology development and scalable pilot scale manufacturing of a dissolvable microneedles patch that is past Phase IIa. He also led the development of a next generation infusion pump which received an Edison Award in the category of “Science & Medical Device Game Changers.” Earlier, at the University of Washington, Dr. Shastry initiated research on super-hydrophobic surfaces for droplet microfluidics. Dr. Shastry has a PhD in Biomedical Engineering, and MS and BS degrees in Chemical Engineering from the Indian Institute of Technology in Mumbai where he initiated BioMEMS research collaborating with Cancer Research Institute. He has authored numerous publications and has over fifteen patents. He serves on the Industrial Advisory Board for UCLA’s Bioengineering Department, is a member of the National Institute of Health Review Panel for Allergy and Infectious Diseases, and the National Science Foundation SBIR Review Panel for Biomedical Technologies and serves on the Editorial Board of Journal of Robotics and Mechanical Engineering Research.